Esperion Therapeutics Inc Capital Reinvestment Ratio

Latest as of March 2024: 0.00x

Esperion Therapeutics Inc capital reinvestment ratio. Esperion Therapeutics Inc (ESPR) has a Capital Reinvestment Ratio of 0.00x as of March 2024, meaning it reinvests 0% of its operating cash flow ($53.83 Million) in capital expenditures ($73.00K). Check Esperion Therapeutics Inc (ESPR) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$53.83 Million

USD

Capital Expenditures

$73.00K

USD

Data as of

Mar 2024

Most recent filing

Esperion Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Esperion Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see how efficiently does Esperion Therapeutics Inc generate cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow